Keyphrases
Adhesion
5%
Adhesion Formation
10%
Adhesion Rate
5%
Adult Patients
5%
Adverse Effects
21%
Between-group
5%
Bleeding
5%
CARE Measure
5%
Chronic Rhinosinusitis
10%
Cochrane
15%
Confidence Interval
10%
Conservative Treatment
5%
Debridement
100%
Disease Severity
21%
Disease-specific Quality of Life
21%
Embase
5%
Endoscopic Features
10%
Endoscopic Score
26%
Endoscopic Sinus Surgery
100%
Endoscopy Outcomes
5%
Follow-up Interval
5%
Group Risk
5%
Health-related Quality of Life
5%
Health-related Quality of Life Scores
10%
High Risk
5%
Iatrogenic Injury
5%
Information Professionals
5%
International Clinical Trials Registry Platform (ICTRP)
5%
Low Adhesion
5%
Low Risk
5%
Lund-Kennedy Score
5%
Methodological Procedures
5%
Nasal
10%
Nasal Douche
5%
No Significant Difference
5%
Non-split
5%
Number-needed-to-treat
5%
One-point
5%
Patency
5%
Patient Care
100%
Patient Symptoms
5%
Patient-reported Symptoms
10%
Pooled Analysis
5%
Postoperative Care
100%
Postoperative Debridement
5%
Postoperative Treatment
15%
Primary Outcome Measure
5%
PubMed
5%
Randomized Controlled Trial
5%
Recurrent Acute Rhinosinusitis
10%
Revision Surgery
15%
Risk of Bias
10%
Risk Ratio
5%
Search Methods
5%
Selection Criteria
5%
Self-control
10%
Severe Pain
5%
Sino-Nasal Outcome Test
5%
Sinonasal
100%
Sinonasal Cavity
10%
Sinus
5%
Surgical Cavity
5%
Symptom Score
10%
Symptomatic Patients
5%
Total Symptom Score
5%
Visual Analog Scale
5%
Web of Science
5%
Medicine and Dentistry
Acute Rhinosinusitis
10%
Adverse Effect
20%
Chronic Rhinosinusitis
10%
Combination Therapy
15%
Conservative Treatment
5%
Debridement
100%
Disease Severity
20%
Diseases
20%
Endoscopy
5%
Functional Endoscopic Sinus Surgery
100%
High Risk Population
5%
Iatrogenesis
5%
Numbers Needed to Treat
5%
Pooled Analysis
5%
Postoperative Care
100%
Quality of Life
25%
Randomized Controlled Trial
5%
Self Control
10%
Visual Analog Scale
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Rhinosinusitis
50%
Chronic Rhinosinusitis
50%
Combination Therapy
75%
Disease Severity
100%
Diseases
100%
Iatrogenic Disease
25%
Number Needed to Treat
25%
Randomized Controlled Trial
25%